date,title,source
Oct-23-18,Neos Therapeutics Licenses Pipeline Candidate for Treatment of Sialorrhea (Excessive Drooling),GlobeNewswire
Nov-05-18,Neos Therapeutics Announces Proposed Offering of Common Stock,GlobeNewswire
